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Abstract: Usnic acid is known for its remarkable antimicrobial activity. The aim of this research was to
formulate hydrogel of usnic acid and evaluate the antibacterial activity against Propionibacterium acne.
Due to low solubility of usnic acid, solid dispersion was prepared using PVP K-30. In this study,
intact usnic acid (UA) and usnic acid-solid dispersion (UA-SD) was formulated in hydrogel using
several gelling agents: Aqupec HV-505, sodium alginate and HPMC K 100M. Concentration of each
gelling agent was optimized for hydrogel base. All of hydrogel base showed homogenous gel, pH at
range 5.37–6.33 and viscosity in range 259.07–10,759.00 cps. Hydrogel was prepared by dispersing
1% intact UA and 3% UA-SD in three different gelling agents. The hydrogel was evaluated for pH,
viscosity, stability test for two months and microbiology test. The amount of usnic acid in hydrogel
was determined by spectrophotometry UV-Vis. Hydrogel UA showed non-homogenous gel, while
hydrogel usnic UA-SD was homogenous. The pH of all hydrogel was in range 5.5–6.4 and viscosity
was 2,017.03–3,866.52 cps. All the hydrogel was stable and diameter inhibition of hydrogel was in
a range 20–32 mm. The amount of usnic acid in hydrogel was in range 96.9–99.23%. In conclusion,
hydrogel UA-SD is promising preparation in handling acne.
Keywords: usnic acid; hydrogel; Propionibacterium acne; solid dispersion
1. Introduction
Usnic acid, a secondary metabolite produced by Usnea sp, is already known for remarkable
pharmacological activities including: anti-bacteria [1], antivirus [2], anti-proliferation [3], anticancer [4],
antioxidant [5], antipyretic and analgesic [6] and anti-inflammation [7]. Usnic acid has two optical
isomers, the (+) and (−) usnic acid, which affected its activity against microorganisms. Both of
enantiomers are potent against Gram-positive bacteria, while the (−) usnic acid has typical activity
as a natural herbicide [8]. Moreover, usnic acid also has a significant activity against anaerobic Gram
positive bacteria including Propionibacterium species [9,10]. Propionibacterium acne, a Gram-positive
and facultative anaerobic bacterium, is one of the normal flora on the skin that in certain conditions
can cause inflammation by producing lipases which break down fatty acids free of skin lipids, known
as acnes [11]. A study has confirmed that usnic acid from Usnea barbata has ability to inhibit the growth
of P. acnes at concentration ≥ 1 µg/mL [12].
There are numerous activities of usnic acid, yet its availability in the market for pharmaceutical
products is still limited. In Indonesia, there is only one commercial product that has been
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marketed—Cream Scabicid® which contained 1% usnic acid. This finite number of product is likely
due to low solubility of usnic acid in water (0.01 g/100 mL) [8]. Some efforts have been done to increase
the solubility of usnic acid, such as complex formation using cyclodextrin [13], microencapsulation
using polymer PLGA [14], milling process [15] and preparation in solid dispersion using HPMC [16].
Our recent study has shown enhancement of usnic acid by preparing it in solid dispersion using
poly-vinyl-pirolidon (PVP) K-30 and its potency as an anti-oxidant was in accordance with the solubility
result [17].
To the best of our knowledge, the was only one application of usnic acid as an anti-acne
that has been investigated and patented by converting usnic acid into salt form or metal salt [18].
Meanwhile, one of the most favourable preparations used for handling acne is hydrogel. Hydrogel
offers convenience in used and has more attractive appearance due to its transparency compared to
other preparations. Moreover, hydrogel is easily washed out and give cool sensation during application
on skin due to water content of the base. Therefore, gelling agents, such as chitosan, HPMC, carbomer,
HPMC, polyvinyl alcohol (PVA) and sodium alginate, play important part in preparing hydrogel [12].
As a preliminary study, this research was focused on the pharmaceutical aspects of hydrogel contained
usnic acid and the potency of usnic acid in order to confirm the activity against P. acnes.
Based on the above considerations, preparation of hydrogel containing intact usic acid and usnic
acid-solid dispersion was carried out in this research. Solid dispersion was prepared using PVP
K-30 in order to increase the solubility of usnic acid [17]. Prior to preparation of usnic acid hydrogel,
concentration of gelling agents used is optimized. Hydrogel of usnic acid was then evaluated by
homogeneity, pH, stability and anti-bacterial test against P. acnes.
2. Materials and Methods
2.1. Materials
(+) Usnic acid (isolated from Usnea sp as explained in previous work [13]), PVP K-30 (Shin-Etsu
Chemical, Tokyo, Japan), Aqupec HV-505 (Sumitomo Seika Chemicals Co., Ltd., Osaka, Japan), sodium
alginate (PT. Kimia Farma, Jakarta, Indonesia), HPMC K 100 M (PT. Kimia Farma, Jakarta, Indonesia),
glycerin (Bratachem, Jakarta, Indonesia), triethanolamine (Bratachem, Jakarta, Indonesia), nutrient
agar (Merck, Darmstadt, Germany), Propionibacterium acnes ATCC 6919 (The Laboratory of Natural
Resource of Sumatra, Padang, Indonesia), clindamycin phosphate gel (Medi-Klin, PT. Surya Dermato
Medika, Surabaya, Indonesia), phosphate buffer (Merck, Darmstadt, Germany), chloroform (Merck,
Darmstadt, Germany), ethanol (Bratachem, Jakarta, Indonesia) and distilled water.
2.2. Optimization of Gelling Agent for Hydrogel Base
Formulation of hydrogel base was prepared using three different gelling agents which were
Aqupec 505 HV, Sodium alginate and HPMC K 100M at different concentration, as seen in Table 1.
Hydrogel base was prepared by dispersing the gelling agent in distilled water until its swelling well.
2.3. Evaluation of Hydrogel Base
Each hydrogel base was evaluated using several parameters included: organoleptic test by
observed its appearance visually; homogeneity test by dispersed about 1 g of each hydrogel sample
was on an object glass and observed its homogeneity; pH measurement by diluted hydrogel into 1%
concentration and pH was determined using pH meter digital (Hanna Instruments, Woonsocket, RI,
USA); viscosity test by using a Brookfield viscometer (Ametek, Berwyn, PA, USA); and wash out test
by applying 1 g each hydrogel to the hand then washed by water.
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Table 1. Preparation of hydrogel base.
Materials
Formula 1 Formula 2 Formula 3
1a 1b 1c 2a 2b 2c 3a 3b 3c
Aqupec HV−505 (%) 0.15 0.175 0.20 − − − − − −
Sodium alginate (%) − − − 1.5 1.75 2 − − −
HPMC K 100 M (%) − − − − − − 1.5 1.75 2
Glycerin (%) 10 10 10 10 10 10 10 10 10
TEA (%) 0.4 0.4 0.4 − − − − − −
Distilled water ad (%) 100 100 100 100 100 100 100 100 100
a, b, and c are the variation of gelling agents concentration used in this study.
2.4. Preparation Solid Dispersion
Solid dispersion of usnic acid PVP K-30 was prepared as described in previous work [15]. Usnic
acid and PVP K-30 at ratio 1:2 (w/w) were dispersed in 100 mL distilled water and stirred until
homogenous. The mixture was then frozen using liquid nitrogen prior to drying process and continued
to primary and secondary drying in freeze dryer apparatus (Christ Alpha 1-2 LD Plus, Osterode,
Germany). The dried powder was then kept in a desiccator.
2.5. Preparation and Evaluation of Hydrogel Usnic Acid (UA) and Usnic Acid in Solid Dispersion (UA-SD)
The optimum concentration of each gelling agent was prepared for hydrogel containing intact
usnic acid and usnic acid in solid dispersion. The amount of usnic acid dispersed in hydrogel was
equivalent to 1% (w/w), so that the amount of usnic acid-solid dispersion was 3% (w/w). Each of
optimal concentration of gelling agent was used in this hydrogel preparation. Furthermore, hydrogel
preparations were evaluated for organoleptic test, homogeneity, pH and viscosity as described in
evaluation of hydrogel base.
2.6. Spreadability and Syneresis Test
Spreadability test was conducted by placing about 0.5 g of hydrogel on transparent glass equipped
with on a graph paper. The hydrogel was covered with transparent plastic and given a certain load
(1, 3, 5 and 7 g) for 15 s. The diameter was measured after being given a load. In addition, syneresis
test was done by storing the hydrogel at 10 ◦C for 24, 48 and 72 h. Each hydrogel was placed on a cup
to hold water released from the gel during storage. Syneresis value was calculated by measuring the
weight loss during storage then compared to the initial weight.
2.7. Usnic Acid Assay in Hydrogel
The amount of usnic acid in hydrogel was determined by a spectrophotometer UV-Vis (Shimadzu,
Japan) at maximum absorption length in phosphate buffer. About 1 g of each hydrogel was dissolved
with 100 mL phosphate buffer pH 7.4 and homogenized by sonication for 2 h. The sample was then
filtered and measured the absorbance at 289 nm. The amount of usnic acid was then calculated based
on linear regression.
2.8. Cycling and Stability Test
Cycling test: The hydrogel was tested for stability against cooling condition. Each sample was
stored at temperature of 0–4 ◦C for 24 h. The homogeneity of each sample was observed and pH was
determined after the cycling test.
Stability test: Each sample of hydrogel was kept in at room temperature for 8 weeks. The stability
of sample was observed every week including the physical appearance, homogeneity and pH test.
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2.9. In Vitro Antibacterial Activity
One ml of Propionibacterium acne suspension stock was put into a sterilized petri dish and added
nutrient agar medium. The mixture was homogenized. About 10 mg of each hydrogel sample was
then put on the wells that has been prepared and incubated for 24 h at 37 ◦C. The ability of hydrogel
samples to inhibit the growth of Propionibacterium acne was determined by measuring diameter
inhibition. As positive and negative controls, a marketed gel containing clindamycin phosphate 1.2%
(Medi-klin) and hydrogel base were tested using the same procedure.
3. Results
3.1. Optimization of Hydrogel Base
The result of hydrogel base optimization is shown in Table 2. All the hydrogel showed transparent
and homogenous gel. Moreover, hydrogel had pH in a range 5.4–6.4 which is acceptable in preparing
hydrogel. However, the viscosity of the F1a was the lowest which was relatively as liquid than gel.
This result was likely due to insufficient amount of gelling agent used to prepare the hydrogel as
described in product description [19], thus the concentration of Aqupec hydrogel influenced the
viscosity. The wash out result denoted that the higher concentration of gelling agent, the more water
need to wash the gel out of the skin. Thus, preparation of hydrogel containing intact usnic acid (UA)
and usnic acid-solid dispersion (UA-SD) was carried out using F1b, F2a and F3a.
Table 2. Result of hydrogel base optimization.
No. Hydrogel Base Homogeneity pH Volume of Wash out Viscosity
1 F1a Homogenous 6.33 16 mL 259.07 cps
2 F1b Homogenous 6.20 17 mL 2595.39 cps
3 F1c Homogenous 6.53 18 mL 3703.75 cps
4 F2a Homogenous 5.40 32 mL 3815.19 cps
5 F2b Homogenous 5.37 37 mL 5115.17 cps
6 F2c Homogenous 6.00 40 mL 14,203.22 cps
7 F3a Homogenous 5.80 40 mL 5544.87 cps
8 F3b Homogenous 5.40 50 mL 9811.03 cps
9 F3c Homogenous 5.40 60 mL 15,811.03 cps
3.2. Hydrogel of Usnic Acid and Usnic Acid—Solid Dispersion
The hydrogel contained usnic acid and usnic acid-solid dispersion showed a yellowish gel which
is shown in Figure 1. The result of homogeneity, pH, viscosity and usnic acid content in hydrogel usnic
acid and usnic acid-solid dispersion is shown in Table 3. The hydrogel of intact usnic acid (UA) was
not homogenous while usnic acid-solid dispersion (UA-SD) was homogenous. This result has been
predicted since the intact usnic acid crystal could not be well dispersed in hydrogel base. Meanwhile,
the addition of usnic acid in hydrogel influence the pH result. Usnic acid is a weak acid that has pKa
4.4 [20]. Moreover, PVP K-30 was used to enhance the solubility of usnic acid [17], which impacted
in reducing the viscosity of hydrogel. This phenomenon was also observed in other study [21,22],
in which PVP maintains adhesion and limits of the physiological range. The amount of usnic acid
in hydrogel was almost close to each formula which indicated that all intact usnic acid and usnic
acid-solid dispersion has the same amount in hydrogel preparation.
Sci. Pharm. 2019, 87, 1 5 of 8
Sci. Pharm. 2018, x, x FOR PEER REVIEW  4 of 8 
 
inhibition. As positive and negative controls, a marketed gel containing clindamycin phosphate 1.2% 
(Medi-klin) and hydrogel base were tested using the same procedure.  
3. Results 
3.1. Optimization of Hydrogel Base 
The result of hydrogel base optimization is shown in Table 2. All the hydrogel showed 
transparent and homogenous gel. Moreover, hydrogel had pH in a range 5.4–6.4 which is acceptable 
in preparing hydrogel. However, the viscosity of the F1a was the lowest which was relatively as 
liquid than gel. This result was likely due to insufficient amount of gelling agent used to prepare the 
hydrogel as described in product description [19], thus the concentration of Aqupec hydrogel 
influenced the viscosity. The wash out result denoted that the higher concentration of gelling agent, 
the more water need to wash the gel out of the skin. Thus, preparation of hydrogel containing intact 
usnic acid (UA) and usnic acid-solid dispersion (UA-SD) was carried out using F1b, F2a and F3a.   
Table 2. Result of hydrogel base optimization. 
No. Hydrogel Base Homogeneity pH Volume of Wash out Viscosity 
1 F1a Homogenous 6.33 16 mL 259.07 cps 
2 F1b Homogenous 6.20 17 mL 2595.39 cps 
3 F1c Homogenous 6.53 18 mL 3703.75 cps 
4 F2a Homogenous 5.40 32 mL 3815.19cps 
5 F2b Homogenous 5.37 37 mL 5115.17 cps 
6 F2c Homogenous 6.00 40 mL 14203.22 cps 
7 F3a Homogenous 5.80 40 mL 5544.87 cps 
8 F3b Homogenous 5.40 50 mL 9811.03 cps 
9 F3c Homogenous 5.40 60 mL 15811.03 cps 
3.2. Hydrogel of Usnic Acid and Usnic Acid—Solid Dispersion  
The hydrogel contained usnic acid and usnic acid-solid dispersion showed a yellowish gel which 
is shown in Figure 1. The result of homogeneity, pH, viscosity and usnic acid content in hydrogel 
usnic acid and usnic acid-solid dispersion is shown in Table 3. The hydrogel of intact usnic acid (UA) 
was not homogenous while usnic acid-solid dispersion (UA-SD) was homogenous. This result has 
been predicted since the intact usnic acid crystal could not be well dispersed in hydrogel base. 
Meanwhile, the addition of usnic acid in hydrogel influence the pH result. Usnic acid is a weak acid 
that has pKa 4.4 [20]. Moreover, PVP K-30 was used to enhance the solubility of usnic acid [17], which 
impacted in reducing the viscosity of hydrogel. This phenomenon was also observed in other study 
[21,22], in which PVP maintains adhesion and limits of the physiological range. The amount of usnic 
acid in hydrogel was almost close to each formula which indicated that all intact usnic acid and usnic 
acid-solid dispersion has the same amount in hydrogel preparation.  
 
Figure 1. Hydrogels of usnic acid in different gelling agent (a) Aqupec, (b) sodium alginate, (c) 
HPMC.  
F1 (b) F2 (a) F3 (a)
a b c
Figure 1. Hydrogels of usnic acid in d fferent gelling agent (a) Aqupec, (b) sodium alginate, (c) HPMC.
Table 3. Result of hydrogel test.
Formula Homogeneity pH Viscosity (cps) Usnic Acid Assay (%)
F1b UA No 5.63 ± 0.09 2328.67 97.56 ± 0.19
F1b UA-SD Homogeneous 5.67 ± 0.05 2270.74 99.23 ± 0.29
F2a UA No 5.70 ± 0.08 2038.95 96.94 ± 0.51
F2a UA-SD Homogeneous 5.50 ± 0.08 2017.03 98.19 ± 0.10
F3a UA No 5.67 ± 0.05 3612.63 96.90 ± 0.29
F3a UA-SD Homogeneous 5.50 ± 0.14 3635.04 97.77 ± 0.29
Spreadability and syneresis test of hydrogel UA and UA-SD were also conducted to characterize
the hydrogel as seen in Table 4. The spreadability value was corresponding to the viscosity result in
previous evaluation. According to the result, the lower viscosity of hydrogel the greater ability to
spread over. Meanwhile, syneresis is the ability of gel to be shrinkage due to change in temperature.
The syneresis result of all hydrogels were similar.
Table 4. Spreadability and syneresis test result.
Formula
Spreadability (cm) Syneresis (g)
Load 0 g Load 1 g Load 3 g Load 5 g Load 7 g 24 h 48 h 72 h
F1b UA 1.90 2.30 2.75 3.25 3.90 11.20 11.13 11.11
F1b UA-SD 2.85 3.45 3.95 4.45 5.10 11.18 11.15 11.14
F2a UA 1.85 2.35 2.70 2.85 3.00 11.05 11.37 11.31
F2a UA-SD 2.05 2.45 2.70 2.95 3.10 11.03 11.03 10.93
F3a UA 2.20 2.70 3.00 3.20 3.40 11.02 11.95 10.95
F3a UA-SD 2.40 2.85 3.15 3.55 3.65 11.04 10.94 11.01
The result of cycling test in Table 5 indicated the stability of hydrogel under cool temperature,
while stability of hydrogel at room temperature for eight weeks can be seen in Table 6. The cycling test
did show similar result of two parameters before and after the test. Similarly, the stability test was
relatively the same after eight-week storage which suggested all hydrogel was stable.
Table 5. Cycling test result.
Formula
pH Homogeneity
Before After Before After
F1b UA 5.63 ± 0.09 5.67 ± 0.00 No No
F1b UA-SD 5.67 ± 0.05 5.67 ± 0.03 Homogeneous Homogeneous
F2a UA 5.70 ± 0.08 5.63 ± 0.05 No No
F2a UA-SD 5.50 ± 0.08 5.47 ± 0.05 Homogeneous Homogeneous
F3a UA 5.67 ± 0.05 5.63 ± 0.05 No No
F3a UA-SD 5.50 ± 0.14 5.20 ± 0.02 Homogeneous Homogeneous
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Table 6. Stability test at room temperature.
Formula
pH Homogeneity
Week 1 Week 2 Week 4 Week 8
F1b 6.30 Homogeneous 6.20 Homogeneous 6.20 Homogeneous 6.20 Homogeneous
F1b UA 5.63 No 5.81 No 5.83 No 5.83 No
F1b UA-SD 5.67 Homogeneous 5.63 Homogeneous 5.63 Homogeneous 5.63 Homogeneous
F2a 6.60 Homogeneous 6.30 Homogeneous 6.00 Homogeneous 6.00 Homogeneous
F2a UA 5.50 No 5.50 No 5.50 No 5.47 No
F2a UA-SD 5.70 Homogeneous 5.70 Homogeneous 5.70 Homogeneous 5.70 Homogeneous
F3a 5.83 Homogeneous 5.73 Homogeneous 5.73 Homogeneous 5.73 Homogeneous
F3a UA 5.50 No 5.43 No 5.43 No 5.43 No
F3a UA-SD 5.57 Homogeneous 5.57 Homogeneous 5.57 Homogeneous 5.57 Homogeneous
3.3. In Vitro Antibacterial Assay
The result of previous evaluations was anticipated to the antibacterial activity of usnic acid in
hydrogel preparation. The diameter zone inhibition of each sample was correlated to the activity of
antibacterial assay against P. acne, which is shown in Table 7 and Figure 2.
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Table 7. Result of anti-bacterial assay.
Formula Diameter Inhibition (mm)± SD
F1b 0 ± 0.00
F1b UA 30 ± 0.05
F1b UA-SD 32 ± 0.05
F2a 0 ± 0.00
F2a UA 29 ± 0.05
F2a UA-SD 30 ± 0.05
F3a 0 ± 0.00
F3a UA 20 ± 0.05
F3a UA-SD 26 ± 0.05
Positive control (+) 30 ± 0.05
All the hydrogel base or negative control showed no inhibition zone which indicated that no
activity of antibacterial activity, see Figure 2a. Meanwhile, the positive control which used clindamycin
gel shows about 30 mm diameter zone inhibition, see Figure 2b. The largest diameter inhibition was
the hydrogel contained usnic acid-solid dispersion using Aqupec as the gelling agent. This result
pointed that the hydrogel of usnic acid which prepared with different gelling agents had the same
activity against P. acnes compared to the marketed and synthetic antibiotics. The potency of usnic
acid as antibacterial is owing to the phenolic groups that known to have antibacterial activity [23].
In addition, the enhancement of antimicrobial activity in solid dispersion against bacteria was also
showed in solid dispersion of usnic acid-polyacrilamide [24].
4. Conclusions
Preparation of hydrogel is influenced by the form of usnic acid used, which solid dispersion of
usnic acid with PVP K-30 provides better result in appearance compared to intact usnic acid. PVP K-30
has not only increased the solubility of usnic acid but also influenced the homogeneity of usnic acid in
hydrogel. The hydrogels were relatively stable after eight-weeks storage. The antibacterial activity
against Propionibacterium acne by hydrogel of usnic acid and usnic acid-solid dispersion was almost
similar to marketed gel contained synthetic antibiotic, which is a promising result for further study.
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